ARCHIVES

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: House Cuts NCI Rescission To $7.73 Million; Weinhuse, Ultmann New ACCR, ASCO Presidents

May 8, 1981

Conversation With The Cancer Letter: Seffrin To Retire After Restructuring ACS

January 24, 2014

NCI Programs: Institute To Expand Career Development, Training Grants

December 18, 1998

IOM Report Recommends Solutions to Problem of Medication Errors.

July 28, 2006

Marie Lombardi NCAB Member, Dies; HHS Holding Up Board Appointments

April 23, 1982

Contract Authority Expiration Confuses NCI Money Bill Estimates, Which Range From $605 To $650 Million

June 21, 1974